Quick Answer
Annovis Bio, Inc. reported Net Income of -$28.85 million for fiscal year 2025.
Annovis Bio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$28.85M | -17.3% |
| 2024 | -$24.59M | +56.2% |
| 2023 | -$56.20M | -121.9% |
| 2022 | -$25.33M | -74.8% |
| 2021 | -$14.49M | -165.2% |
| 2020 | -$5.46M | -451.2% |
| 2019 | -$991.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.26M | +42.5% | -16.8% |
| June 30, 2025 | -$6.22M | -23.9% | -12.3% |
| March 31, 2025 | -$5.54M | -419.0% | +56.2% |
| September 30, 2024 | -$12.64M | +14.1% | -151.7% |
| June 30, 2024 | -$5.02M | +47.4% | -370.5% |
| March 31, 2024 | -$1.07M | +89.0% | +92.8% |
| September 30, 2023 | -$14.72M | -128.8% | -54.3% |
| June 30, 2023 | -$9.54M | -60.7% | +2.1% |
- Annovis Bio, Inc. showed a decrease of -17.3% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Annovis Bio, Inc.’s net income has declined by 2811.7% (from -$991.0 thousand to -$28.85 million).
- The most recent figure is from Annovis Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: